More than 4,000 products to delete from NHI reimbursement schedule.

Under the positive list system exercise, it is estimated for about 4,000 drugs with no records of production nor billing during the past 2 years to be deleted from the NHI reimbursement schedule.

However, the deleting plan may be reviewed at the next meeting for exit protecting products, orphan drugs and a part of drugs with high strength to allow a relief possibility.

Prof. Shin Hyeon-ta...